GUIDELINES FOR SUBMITTING AN ABSTRACT TO UCHID Cairo 2019.

General information

Thank you for your interest in submitting an abstract to UCHID Cairo 2019!

UCHID 2019 is proud to announce a prize for accepted abstract in one of the fields: HEPATOLOGY, GASTROENTEROLOGY AND INFECTIOUS DISEASES.

Top Abstract Prize will be granted 600 $ as well as free registration, to be awarded to the first author (principle investigator), who should also be the presenting author.

Accepted abstracts will be published as a supplement, either in printed format, electronically or both, to the Journal of Advanced Research. UCHID requires an exclusive license to publish the accepted abstract, which you need to grant on behalf of all authors of the abstract as part of your submission of an abstract to UCHID.

  • Top Abstract Prize will be granted in one of the previously mentioned fields as 600 $ as well as free registration, to be awarded to the first author (principle investigator), who should also be the presenting author.

Accepted abstracts will be published as a supplement, either in printed format, electronically or both, to the Journal of Advanced Research. UCHID requires an exclusive license to publish the accepted abstract, which you need to grant on behalf of all authors of the abstract as part of your submission of an abstract to UCHID.

  • Abstracts may only be submitted online via the conference website https://www.uchid-eg.com From 1 June 2019 until the deadline. Abstracts sent by mail, e-mail or fax will not be accepted.
  • Participants are welcome to submit original scientific abstracts for oral and poster presentations, provided that the abstracts have not been previously published as a full paper. Abstracts will not be considered for presentation if they have been published as a full article or paper or if they have been accepted for publication (including manuscripts) in printed or electronic formats upon the dead line for abstract submission.
  • Authors are requested to abide to guidelines for submission. Abstracts not conforming to the guidelines will not be referred for review.
  • For all accepted presentations, the presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission. Please note that the abstract content may be minorly edited by the scientific committee.

SUBMISSION OF ABSTRACTS:

  1. All abstracts must be submitted and presented in English. Please have your abstract proofread for grammar and understanding.
  2. The authors’ names (full first names, family names), gender and places of work (institution, city, country) must be shown. 
  1. Please structure your abstract using the following headings in the template:

Introduction: Identifies the aim of the research
Methods: Describes the methods applied, study design and the all the details regarding the selection and of the participants of the study
Results: Provides information regarding the results of the research
Conclusions: addressing relevant implications for clinical practice or health policy

  1. All abbreviations must be defined the first time they appear in your text. Example: Transient Elastography (TE), before being used as an abbreviation only. Abbreviations should not be used in the title.
  1. Choose one primary topic listed on the website (Hepatology, Gastroenterology, or Infectious diseases) which best corresponds to the content of your abstract.
  1. The length of the abstract (incl. introduction, aims & methods, results, conclusion and tables) must not exceed 3,600 printable characters (incl. spaces). The title of the abstract, references and disclosure are counted separately. Authors and affiliations are not included in the character count.
  1. Indicate minimum 2, maximum 3 keywords which best correspond to the content of your abstract.
  1. The use of trademarks is prohibited, only International Non-proprietary Names (INN), e.g. generic drug names, are allowed.
  1. Only one of the following is allowed per abstract:
    -Images: Images should be JPG/BMP format, maximum width 9cm, and resolution up to 150dpi. Please note that these may be resized to fit in the final printed material.
    -Graphs: Graphs should be with similar resolution and size as depicted above. – Tables: Tables must be added as a table and not as an image. The characters used in the table count toward the total character count of the abstract (max 2500).
  1. If your research has been granted any commercial or institutional support, please disclose this during the submission process.
  • Should you wish to make corrections to an abstract already submitted please contact us via e-mail. Corrections to abstracts can only be made up to the announced submission deadline.
  • Submission of an abstract constitutes a formal commitment by the author to present the abstract in the session and at the time decided upon by the UCHIDScientific Committee. In case of any change, the presenting author needs to communicate in the form of a written statement with the scientific committee. If the original presenting author is unable to present the abstract, it is that person’s responsibility to ensure that one of the co-authors takes over this role. Failure to present the abstract for other than well-founded reasons will lead to rejection of abstracts submitted at the next UCHID meeting.

Further information:

Research ethics and patient consent:


In cases where the manuscripts submitted include data related to involvement of humans/animals or human/animal derived products or the medical reports of humans should have approval from the relevant Institutional Review Board or the Ethics committee. All the researches involving humans should be strictly conducted in accordance to the Declaration of Helsinki.

In cases where the details/ results/images of the patients are utilized, information on the informed consent should be reported in the abstract text.

Plagiarism and Uniqueness:


we encourage authors to follow strict guidelines and follow the standard Editorial Process to maintain high quality content in the submitted abstract. To achieve such standards, we encourage you to avoid plagiarism, redundancy of abstracts, Duplicate submissions, fabrication and falsification of data.

Plagiarism: plagiarism constitutes the inappropriate use of the others intellectual property. The duplication of the content (sentences/paragraphs) from already published or someone else’s work, even though cited in the bibliography section.

Plagiarism is not limited to txt content but also includes duplication of the images and contents in the tables.

Duplicate submissionsThe author could not submit the abstract which have been previously published or under evaluation for publication, on such instances the submissions would be considered as duplicate submissions.

Fabrication and Falsification of data Data fabrication is making up data or results and recording or reporting the fabricated information without carrying out the study. Falsification includes the manipulating research materials, equipment, processes, changing, and selective omission/deletion/suppression of conflicting data without scientific or statistical justification.

Errors and correction:


In case of errors in the published articles the authors are obliged to notify the scientific committee. The corrections will be reviewed by the reviewers in charge of your abstract.

 

References:


Authors are responsible for the accuracy and completeness of their references and for correct text citation.

  • References should follow the text and begin on a separate page.
  • References must be double line spaced and numbered consecutively in order of appearance within the text, using the automated numbering tool of Word.
  • Identify references in text, tables, and legends in Arabic numerals in parentheses, i.e. (7).
  • List all authors when six or fewer; when seven or more, list only the first three and add et al.
  • References used within tables or figure legends should be included in the reference list and numbered in consecutive order according to the table/figure citation in the text.
  • Journals’ names should be abbreviated according to Index Medicus/Medline. If there is any doubt about abbreviation of a journal name, it should be spelled out completely.
  • Any references to studies (including books or articles) that have been accepted for publication, but not yet published, should indicate where they will be published and have the term “in press” in the reference in place of volume and page numbers. These must be updated prior to publication, if possible.
  • Do not add a discussion or comment to a reference.
  • Suffixes such as Jr, Sr, and III follow author’s initials.

Examples of reference style:

  1. Journal Article
    Micha R, Peñalvo JL, Cudhea F, et al. Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States. 2017; 317(9):912-924.
  2. Book
    Domino FJ, Baldor RA, Grimes JA, Golding J, eds. 5-Minute Clinical Consult. 23rd ed. Philadelphia, PA: Lippincott Williams & Wilkins 2014; 492-498.
  3. Chapter in book
    Yaksh TL, Luo ZD. Anatomy of the pain processing system. In: Waldman SD, ed. Pain Management. 2nd ed. Philadelphia, PA: Elsevier/Saunders 2011; 10-18.
  4. Webpage reference
    References to web sites must always include the full link. (E.g. FDA Drug Safety Communication: FDA warns about rare but serious allergic reactions with the skin antiseptic chlorhexidine gluconate. https://www.fda.gov/Drugs/DrugSafety/ucm530975.htm)

If you have questions regarding abstracts or need assistance, please contact the abstract team at abstracts@uchid-eg.com

Should you wish to make corrections to an already submitted abstract, or if you wish to submit other abstracts later, you may use your abstract reference number. Corrections to regular abstracts can only be made up to the submission deadline: 15 July 2019.

01 June 2019

Abstract submission opens

15 July 2019

Abstract submission deadline

01 August 2018

Abstract notification to authors will begin

15 August 2019

Final day to withdraw accepted abstracts and/or to request modifications of titles and author lists

Formatting comments:

  • Font: times new roman 12, title of the abstract 14 and bold.
  • The abstract should be without headings like Introduction, methods or conclusion. It must be one whole paragraph.
  • Authors’ names should be written as follows: Full first name, middle initial, then full surname.
  • Superscript lowercase letters should be used instead of numbers for various affiliations
  • Affiliations should be detailed:

Department, faculty/college, University, city with zip code or P.O. Box and country.

 

  • Please order each abstract following the example.
  • 1) Title
    2) Authors

3) Affiliations

4) Details of the corresponding authorand/orpresenter

5) Abstract (one whole paragraph)

6) Keywords

 

.